| Literature DB >> 28676088 |
Qhtan Asmaa1, Salwa Al-Shamerii2, Mohammed Al-Tag3, Adam Al-Shamerii4, Yiping Li5, Bashir H Osman6.
Abstract
BACKGROUND: The leishmaniasis is a group of diseases caused by intracellular haemoflagellate protozoan parasites of the genus Leishmania. Leishmaniasis has diverse clinical manifestations; cutaneous leishmaniasis (CL) is the most common form of leishmaniasis which is responsible for 60% of disability-adjusted life years. CL is endemic in Yemen. In Shara'b there is no reference study available to identify the prevalence of endemic diseases and no investigation has been conducted for diagnosing the diseases.Entities:
Keywords: Free radicals scavengers; Leishmaniasis; Malondialdehyde; Prevalence; Yemen
Mesh:
Substances:
Year: 2017 PMID: 28676088 PMCID: PMC5496594 DOI: 10.1186/s12941-017-0224-y
Source DB: PubMed Journal: Ann Clin Microbiol Antimicrob ISSN: 1476-0711 Impact factor: 3.944
Fig. 1Map of Taiz Governorate, Yemen, shows Shara’b District
Fig. 2Prevalence of CL infection in Shara’b district, Taiz, Yemen
Fig. 3Percent of distribution Leishmania infection in villages
Rate of CL infection in relation to sex
| Sex | No. examined | Overall infection | Odds ratio | (95% CI) | P value | |
|---|---|---|---|---|---|---|
| No. | % | |||||
| Male | 243 | 47 | 19.3 | 0.011 | 0.833–0.813 | 0.044* |
| Female | 282 | 52 | 18.4 | |||
* Significant (P < 0.05)
Fig. 4Distribution of cutaneous leishmaniasis among examined cases, according to sex
Prevalence of CL infection among cases examined, in relation to age and sex groups
| Age group | Gender | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Male | Female | P value | Odds ratio | (95% CI) | Overall infection P value | |||||
| No examined | No +ve | % +ve | No examined | No +ve | % +ve | |||||
| 1–15 | 88 | 20 | 22.7 | 114 | 21 | 18.4 | 0.013* | 0.458 | 0.943–0.933 | 0.024* |
| 16–30 | 90 | 16 | 17.8 | 86 | 16 | 18.6 | 0.373n | |||
| 31–45 | 43 | 8 | 18.6 | 65 | 11 | 16.9 | 0.410n | |||
| 46–60 | 22 | 3 | 13.6 | 17 | 4 | 23.5 | 0.002* | |||
| Total | 243 | 47 | 19.3 | 282 | 52 | 18.4 | 0.555n | |||
nnon-significant
* Significant difference at (0.05)
Fig. 5Distribution of lesions on various parts of patients infected with CL
Fig. 6Type of scar on body description infection with CL
Fig. 7Pictures of lesions in patients with CL. a Typical lesion sever inflammatory. b Dry lesion on nose. c Local and dry lesion on ear. d Extensive lesion on cheek. e Dry lesion after skin scraping. f Dry lesion on upper lip
Fig. 8Pictures of lesions in patients with CL. a Large lesion on right hand. b Lesion under lower lip. c 1 Dry lesion and 2 fungi infection. d Chancrous lesion on left leg
Distribution of CL lesions according to site of lesion and age groups
| Infected groups | Site of lesions | Total | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No describe | Hands | Legs | Hands and legs | Ears | Cheeks | Lips | Nose | Ear and hands | Ear and cheek | |||
| Child (1–15) | % of total count | 1 | 2 | 1 | 1 | 13.1 | 9.1 | 10.1 | 1 | 1 | 2 | 41.4 |
| % with site scars | 50.0 | 8.7 | 20.0 | 50.0 | 92.9a | 37.5 | 58.8 | 25.0 | 25.0 | 50.0 | 41.4 | |
| Count | 1 | 2 | 1 | 1 | 13 | 9 | 10 | 1 | 1 | 2 | 41 | |
| Adult (16–60) | % of total count | 1 | 21.2 | 4 | 1 | 1 | 15.2 | 7.1 | 3 | 3 | 2 | 58.6 |
| % with site scars | 50 | 91a | 80 | 50 | 7.1 | 62 | 41 | 75 | 75 | 50 | 58.6 | |
| Count | 1 | 21 | 4 | 1 | 1 | 15 | 7 | 3 | 3 | 2 | 58 | |
| Total | 2 | 23 | 5 | 2 | 14 | 24 | 17 | 4 | 4 | 4 | 99 | |
aHigh percent
Rate of cutaneous leishmaniasis infection in relation to certain social factors
| Parameter | No. examined | Overall infection | Odds ratio | (95% CI) | P value | |
|---|---|---|---|---|---|---|
| No. | % | |||||
| Primary | 86 | 18 | 18.2 | 3.955 | 0.443–0.424 | 0.412n |
| Secondary | 81 | 18 | 18.2 | |||
| Diploma | 22 | 4 | 4.0 | |||
| Bachelor | 14 | 5 | 5.1 | |||
| Total | 322 | 54 | 54.6 | |||
n no significant P > 0.05
Effect of certain environmental and others social factors on infection with CL
| Parameter | No. examined | Over all infection | Odds ratio | (95% CI) | P value | |
|---|---|---|---|---|---|---|
| No. | % | |||||
| Residents type | ||||||
| Populist | 346 | 65 | 12.38 | 0.035 | 0.985–0.456 | 0.040* |
| New | 179 | 34 | 6.47 | |||
| Floor type | ||||||
| First floor | 270 | 61 | 51.42 | 5.50 | 0.778–0.066 | 0.030* |
| Second floor | 237 | 34 | 45.14 | |||
| Third floor | 18 | 4 | 3.43 | |||
| House protection | ||||||
| Found protection | 294 | 55 | 10.4 | 0.010 | 1.00–0.922 | 0.040* |
| Not found | 231 | 44 | 8.38 | |||
| Animals found | ||||||
| Found | 314 | 59 | 11.23 | 0.002 | 1.00–0.524 | 0.023* |
| Not found | 211 | 40 | 7.6 | |||
* Significant P < 0.05
Levels of maloniadealdhyde (MDA), catalase (Cat.) and uric acid (UA) of patients and healthy control
| Test | Number | Mean ± SEM | P value |
|---|---|---|---|
| UA mg/l | Patient (99) | Patient 8.5 ± 0.27 | <0.001* |
| Cat. kU/l | Patient (99) | Patients 72.5 ± 4.5 | 0.115n |
| MDA nM/ml | Patient (99) | Patients 3.40 ± 0.06 | <0.001* |
n no significant P > 0.05
* Significant P < 0.05
Serum levels of maloniadealdhyde (MDA), catalase (Cat.) and uric acid (UA) in relation to age groups of patients infected with CL
| Groups | N | Mean ± SEM | P value |
|---|---|---|---|
| UA mg/l | |||
| 1–15 | 28 | 8.62 ± 0.42 | 0.402n |
| 16–30 | 38 | 8.93 ± 0.50 | |
| 31–45 | 28 | 7.77 ± 0.50 | |
| 45–60 | 5 | 8.28 ± 1.49 | |
| Total | 99 | 8.4892 ± 0.27 | |
| Cat. kU/l | |||
| 1–15 | 28 | 81.96 ± 9.7 | 0.828n |
| 16–30 | 38 | 85.34 ± 7.9 | |
| 31–45 | 28 | 79.49 ± 8.9 | |
| 45–60 | 5 | 103.11 ± 27. 5 | |
| Total | 99 | 83.43 ± 4.9 | |
| MDA nM/ml | |||
| 1–15 | 28 | 3.49 ± 0.13 | 0.139n |
| 16–30 | 38 | 3.49 ± 0.09 | |
| 31–45 | 28 | 3.23 ± 0.12 | |
| 45–60 | 5 | 2.92 ± 0.30 | |
| Total | 99 | 3.39 ± 0.06 | |
n no significant P > 0.05
Effect of sex on catalase among patients and control groups
| Sex | Catalase | ||||
|---|---|---|---|---|---|
| No. | Mean ± SEM | CI 95% | χ2 | P value | |
| Males patients | 47 | 73.100 ± 0.021 | 0.439 | 39.0 | 0.561n |
| Females patients | 52 | 72.29 ± 0.014 | 0.539 | 44.0 | 0.461n |
| Males control | 27 | 83.1 ± 0.49 | 0.0.477 | 138 | 0.523n |
| Females control | 24 | 80.1 ± 0.32 | 0.677 | 140 | 0.323n |
n no significant P > 0.05
Effect of age on uric acid levels among patients and control
| Age group | Uric acid | ||
|---|---|---|---|
| χ2 | OR | P value | |
| Patients | 3900.187 | 692.471 | 0.363n |
| Control | 1063.91 | 293.908 | 0.182n |
n no SIGNIFICANT P value >0.05
Effect of age on catalase levels among patient and control groups
| Age group | Catalase | ||
|---|---|---|---|
| χ2 | OR | P value | |
| Patients | 40.5 | 0.0512 | 0.213n |
| Control | 63.48 | 0.033 | 0.588n |
n no significant P > 0.05
Effect of sex on uric acid level among infected group with CL and control group
| Test group | Sex | Number | Mean and SEM | P value |
|---|---|---|---|---|
| Uric acid | Patients males | 47 | 9.70 ± 0.35 | 0.050 |
| Control males | 27 | 6.62 ± 0.40 | 0.527n | |
| Patients females | 52 | 8.10 ± 0.44 | 0.511n | |
| Control females | 24 | 6.91 ± 0.41 | 0.492n |
n no significant P > 0.05
* Significant P < 0.05